Results 291 to 300 of about 765,314 (335)

Adjuvant Radiotherapy for Surgically Resected Stage III Merkel Cell Carcinoma.

JAMA Surg
Pairawan SS, Dominguez CE, Solomon N, Caba-Molina D, O'Leary M, Reeves ME, Namm JP.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Adjuvant Radiotherapy for Keloids

Aesthetic Plastic Surgery, 2021
Radiotherapy is one of the therapeutic methods for keloids, and the irradiation technique has innovated from superficial X-ray to brachytherapy after decades of clinical practice. At present, the application of adjuvant radiotherapy has been widely accepted by clinicians, while the consensus of optimal adjuvant radiotherapy strategies for keloids has ...
Wenfang Dong, B. Qiu, F. Fan
semanticscholar   +3 more sources

Efficacy and prognostic factors of adjuvant radiotherapy for cutaneous squamous cell carcinoma: A systematic review and meta‐analysis

Journal of the European Academy of Dermatology and Venereology, 2021
Although adjuvant radiotherapy has been used for cutaneous squamous cell carcinoma, its outcome benefits, especially for patients with clear surgical margins, have not been statistically estimated, and the characteristics that can indicate patients who ...
Jinjue Zhang, Yixi Wang, Wilson A. Wijaya, Zhong-xiao Liang, Junjie Chen   +4 more
semanticscholar   +1 more source

ATP‐Responsive Smart Hydrogel Releasing Immune Adjuvant Synchronized with Repeated Chemotherapy or Radiotherapy to Boost Antitumor Immunity

Advances in Materials, 2021
Certain chemotherapeutics and forms of ionizing radiation can induce immunogenic cell death (ICD). If there simultaneously exist immune adjuvants within the tumor, such antitumor immunity would be further amplified.
Lele Sun, Fengyun Shen, Longlong Tian, Huiquan Tao, Zijian Xiong, Jun Xu, Zhuang Liu   +6 more
semanticscholar   +1 more source

Adjuvant radiotherapy in urothelial neuroendocrine carcinoma

Minerva Chirurgica, 2020
Neuroendocrine carcinoma cases, more frequent in the gastro-intestinal and pulmonary tract, have rarely been reported also in other areas, including the genito-urinary system. The majority of genitourinary neuroendocrine carcinomas occur in the bladder, being upper urinary tract neuroendocrine carcinoma rare.
Rossi R. E., Monteleone M., Altomare M., Cattaneo L., Torchio M., Coppa J., Mazzaferro V.   +6 more
openaire   +3 more sources

The Impact of Adjuvant Radiotherapy on Carcinosarcoma of the Uterus [PDF]

Gynecologic Oncology, 1998
The role of adjuvant radiotherapy in the setting of uterine carcinosarcoma has not been clearly established.A retrospective review of 60 patients receiving definitive therapy for carcinosarcoma of the uterus was undertaken at a single institution.
Joseph L. Kelley, Quingshou Huang, Clare M. Faul, Sophia Kounelis, Kristina Gerszten, Mirka W. Jones   +5 more
openaire   +2 more sources

Adjuvant radiotherapy for breast cancer

BMJ, 2008
Changes in delivery must be driven by evidence from ongoing clinical trials The incidence of breast cancer is rising worldwide, particularly in women over 50—it increased by 30-40% between 1973 and 1997.1 In the United States it has decreased by around 10% in line with the reduced use of hormone replacement therapy, but globally the problem is growing.
Hiley, Crispin, Tutt, Andrew, Torres, Mylin, Palmieri, Carlo   +3 more
openaire   +3 more sources

Chemotherapy as an Adjuvant to Radiotherapy

1967
The rationale of combining a chemotherapeutic agent with radiation therapy can be on one of two hypotheses: 1. Agents like 5-fluorouracil (5-FU) or 5-bromodeoxyuridine (5-BUdR) have been shown to be radiation sensitizers (Bagshaw, 1961; Berry and Andrews, 1962; Bosch et al., 1958; Djordjevic and Szybalski, 1960, Kaplan et al., 1961, 1962 ...
Robert D. Lindberg, Herman D. Suit, Gilbert H. Fletcher, C. D. Howe, Melvin L. Samuels, Richard H. Jesse, J. P. Smith   +6 more
openaire   +2 more sources